Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases

BACKGROUND: Yttrium-90 (Y-90) can be an effective liver-directed therapy for patients with metastatic neuroendocrine tumors (NETs), but population-based data are limited. We characterized the use of Y-90 in NET patients and identified factors associated with response. METHODS: We identified 49 patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Gastroenterol Hepatol
Main Authors: Tsang, Erica S., Loree, Jonathan M., Davies, Janine M., Gill, Sharlene, Liu, David, Ho, Stephen, Renouf, Daniel J., Lim, Howard J., Kennecke, Hagen F.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704205/
https://ncbi.nlm.nih.gov/pubmed/33299824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5104082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados